Daniel W. Scholfield
Imperial College Healthcare NHS Trust, Memorial Sloan Kettering Cancer Center
Papers
3
Total Citations
15
H-Index
2
About
Daniel W. Scholfield is a head and neck surgeon whose research focuses on the intersection of oncologic efficacy and functional preservation, particularly in oropharyngeal squamous cell carcinoma (OPSCC). His work centers on the paradigm shift in managing HPV-positive OPSCC, where improved survival rates demand treatment strategies that prioritize quality of life without compromising oncologic outcomes. Scholfield’s most cited paper (2020, 12 citations) demonstrates how transoral robotic surgery (TORS) can achieve this balance, offering superior functional swallowing outcomes compared to traditional open approaches. He further explores the nuances of surgical de-escalation in a 2025 publication, documenting the evolution from morbid mandibulotomy procedures to minimally invasive techniques that reduce tracheostomy and gastrostomy dependence. His systematic review on tongue base mucosectomy (2024) critically evaluates quality-of-life impacts in occult primary cancers, addressing a gap in validated outcome measurement. With a career spanning landmark shifts in oropharyngeal cancer management, Scholfield’s work directly informs clinical decision-making for patients with HPV-positive disease, where the challenge is no longer just survival, but thriving after treatment. His research is essential reading for surgeons and oncologists navigating the delicate balance between cure and function.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3